Taubman Institute 7th annual symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
The treatment he designed is credited as the first successful and sustained demonstration of the use of gene transfer therapy to turn the body’s own immune cells into weapons aimed at cancerous tumors.
The research is considered a landmark breakthrough in treating blood cancers that have stopped responding to conventional therapies, or for patients who are not candidates for bone marrow transplants, which carry a high mortality risk.
The symposium also will feature presentations by Taubman Scholars including:
John Carethers, M.D., John G. Searle Professor and Chair, Department of Internal Medicine
Kathleen Collins, M.D., Ph.D., Professor of Internal Medicine
Pavan Reddy. M.D., Moshe Talpaz Professor of Translational Oncology
The lectures will be preceded by a scientific poster session and coffee hour. All events will take place in the A. Alfred Taubman Biomedical Science Research Building in Ann Arbor.
No registration is required.
Visiting Professor lecture to focus on restoring vision loss
Robin Ali, Ph.D., a pioneer in the use of gene therapy and stem cells to restore damaged retinas, will speak in Ann Arbor on Nov. 5.
Click here for details.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
In the News
PBS series features institute director
"The Embrace of Aging," a documentary series airing Sundays at 2:30 p.m. on Detroit Public Televsion, features several interviews with Taubman Institute Director Eva Feldman, M.D., Ph.D.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.